Evidence map›Paper›PMID 40704399›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2025

Deep Learning to Differentiate Parkinsonian Syndromes Using Multimodal Magnetic Resonance Imaging: A Proof-of-Concept Study.

Giulia Maria Mattia, Lydia Chougar, Alexandra Foubert-Samier, Wassilios G Meissner, Margherita Fabbri, Anne Pavy-Le Traon, Olivier Rascol, David Grabli, Bertrand Degos, Nadya Pyatigorskaya and 5 more

Abstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Giulia Maria MattiaUniv Toulouse, Inserm, ToNIC, Toulouse, France.ORCID https://orcid.org/0000-0002-6752-367X
Lydia ChougarSorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, AP-HP, CNRS 7225, Inserm 1127, Hôpital de la Pitié Salpêtrière, Department of Neuroradiolog, Paris, France.ORCID https://orcid.org/0000-0001-9306-5687
Alexandra Foubert-SamierUniv. de Bordeaux, CNRS, IMN, UMR 5293, Bordeaux, France.
Wassilios G MeissnerUniv. de Bordeaux, CNRS, IMN, UMR 5293, Bordeaux, France.ORCID https://orcid.org/0000-0003-2172-7527
Margherita FabbriUniv Toulouse, Inserm, ToNIC, Toulouse, France.ORCID https://orcid.org/0000-0001-7250-592X
Anne Pavy-Le TraonUniv Toulouse, Inserm, ToNIC, Toulouse, France.
Olivier RascolUniv Toulouse, Inserm, ToNIC, Toulouse, France.ORCID https://orcid.org/0000-0002-1410-6397
David GrabliSorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, AP-HP, CNRS, Inserm, Hôpital de la Pitié Salpêtrière, Department of Neurology, Paris, France.
Bertrand DegosAssistance Publique Hôpitaux de Paris, Service de Neurologie, Hôpital Avicenne, Hôpitaux Universitaires de Paris Seine-Saint-Denis, Sorbonne Paris Nord, NS-PARK/FCRIN Network, Bobigny, France.ORCID https://orcid.org/0000-0001-5644-1292
Nadya PyatigorskayaSorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, AP-HP, CNRS 7225, Inserm 1127, Hôpital de la Pitié Salpêtrière, Department of Neuroradiolog, Paris, France.
Alice FaucherAssistance Publique Hôpitaux de Paris, Service de Neurologie, Hôpital Avicenne, Hôpitaux Universitaires de Paris Seine-Saint-Denis, Sorbonne Paris Nord, NS-PARK/FCRIN Network, Bobigny, France.
Marie VidailhetSorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, AP-HP, CNRS, Inserm, Hôpital de la Pitié Salpêtrière, Department of Neurology, Paris, France.
Jean-Christophe CorvolSorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, AP-HP, CNRS, Inserm, Hôpital de la Pitié Salpêtrière, Department of Neurology, Paris, France.ORCID https://orcid.org/0000-0001-7325-0199
Stéphane LehéricySorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, AP-HP, CNRS 7225, Inserm 1127, Hôpital de la Pitié Salpêtrière, Department of Neuroradiolog, Paris, France.
Patrice PéranUniv Toulouse, Inserm, ToNIC, Toulouse, France.ORCID https://orcid.org/0000-0001-7200-0139

Funding

Agence Nationale de la Recherche Projet-ANR-20-CE17-0028Collège des Enseignants en Radiologie de France (CERF)Société Française de Neuroradiologie (SFNR)Société Française de Radiologie (SFR)
6 · The paper itself

Abstract

backgroundThe differentiation between multiple system atrophy (MSA) and Parkinson's disease (PD) based on clinical diagnostic criteria can be challenging, especially at an early stage. Leveraging deep learning methods and magnetic resonance imaging (MRI) data has shown great potential in aiding automatic diagnosis.

objectiveThe aim was to determine the feasibility of a three-dimensional convolutional neural network (3D CNN)-based approach using multimodal, multicentric MRI data for differentiating MSA and its variants from PD.

methodsMRI data were retrospectively collected from three MSA French reference centers. We computed quantitative maps of gray matter density (GD) from a T1-weighted sequence and mean diffusivity (MD) from diffusion tensor imaging. These maps were used as input to a 3D CNN, either individually ("monomodal," "GD" or "MD") or in combination ("bimodal," "GD-MD"). Classification tasks included the differentiation of PD and MSA patients. Model interpretability was investigated by analyzing misclassified patients and providing a visual interpretation of the most activated regions in CNN predictions.

resultsThe study population included 92 patients with MSA (50 with MSA-P, parkinsonian variant; 33 with MSA-C, cerebellar variant; 9 with MSA-PC, mixed variant) and 64 with PD. The best accuracies were obtained for the PD/MSA (0.88 ± 0.03 with GD-MD), PD/MSA-C&PC (0.84 ± 0.08 with MD), and PD/MSA-P (0.78 ± 0.09 with GD) tasks. Patients misclassified by the CNN exhibited fewer and milder image alterations, as found using an image-based z score analysis. Activation maps highlighted regions involved in MSA pathophysiology, namely the putamen and cerebellum.

conclusionsOur findings hold promise for developing an efficient, MRI-based, and user-independent diagnostic tool suitable for differentiating parkinsonian syndromes in clinical practice. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

Deep LearningMagnetic Resonance ImagingMultimodal ImagingMultiple System AtrophyParkinson DiseaseParkinsonian DisordersAgedDiagnosis, DifferentialFemaleHumansMaleMiddle AgedProof of Concept StudyRetrospective Studiesconvolutional neural networkdifferential diagnosisinterpretabilitymultiple system atrophyParkinson's disease

Identifiers

PMID40704399
PMCPMC12553993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.